Structural and thermodynamic basis for the interaction of the Src SH2 domain with the activated form of the PDGF β-receptor

Journal of Molecular Biology

Volumn 328, Issue 3, 2003, Pages 655-668

  Lubman, Olga Y ^a   Waksman, Gabriel ^a,b,c  

^a WASHINGTON UNIVERSITY   (United States)

^b UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Calorimetry; PDGF receptor; SH2 domain; X ray crystallography

Indexed keywords

PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN KINASE;

AMINO ACID SEQUENCE; ARTICLE; CALORIMETRY; CARBOXY TERMINAL SEQUENCE; ENERGY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; THERMODYNAMICS; WATER ANALYSIS; X RAY CRYSTALLOGRAPHY;

EID: 0037414445     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2836(03)00344-9     Document Type: Article

References (57)

1. Boström H., Willetts K., Pekny M., Levéen P., Lindahl P., Hedstrand H., et al. PDGF-A signaling is a critical event in lung alveolar myofibroblast development and alveogenesis. Cell. 85:1996;863-873.
2. Levéen P., Pekny M., Gebre-Medhin S., Swolin B., Larsson E., Betsholtz C. Mice deficient for PDGF-B show renal, cardiovascular, and hematological abnormalities. Genes Dev. 8:1994;1875-1887.
3. Soriano P. Abnormal kidney development and hematological disorders in PDGF b-receptor mutant mice. Genes Dev. 8:1994;1888-1896.
4. Soriano P. The PDGFa receptor is required for neural crest cell development and for normal patterning of the somites. Development. 124:1997;2691-2700.
5. Heldin C.-H., Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol. Rev. 79:1999;1283-1316.
6. Claesson-Welsh L., Eriksson A., Westermark B., Heldin C.-H. cDNA cloning and expression of the human A-type platelet-derived growth factor (PDGF) receptor establishes structural similarity to the B-type PDGF receptor. Proc. Natl Acad. Sci. USA. 86:1989;4917-4921.
7. Matsui T., Heidaran M., Miki T., Toru M., Popescu N., La Rochelle W., et al. Isolation of a novel receptor cDNA establishes the existence of two PDGF receptor genes. Science. 243:1989;800-803.
8. Yarden Y., Escobedo J.A., Kuang W.-J., Yang-Feng T.L., Daniel T.O., Tremble P.M., et al. Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors. Nature. 323:1986;226-232.
9. Pawson T., Schlessinger J. SH2 and SH3 domains. Curr. Biol. 3:1993;434-442.
10. Ullrich A., Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell. 61:1990;203-212.
11. Erpel T., Courtneidge S.A. Src family protein tyrosine kinases and cellular signal transduction pathways. Curr. Opin. Cell Biol. 7:1995;176-182.
12. Kypta R.M., Goldberg Y., Ulug E.T., Courtneidge S.A. Association between the PDGF receptor and members of the src family of tyrosine kinases. Cell. 62:1990;481-492.
13. Ralston R., Bishop J.M. The product of the proto-oncogene c-src is modified during the cellular response to platelet-derived growth factor. Proc. Natl Acad. Sci. USA. 82:1985;7845-7849.
14. Thomas S.M., Brugge J.S. Cellular functions regulated by Src family kinases. Annu. Rev. Cell. Dev. Biol. 13:1997;513-609.
15. Anderson D., Koch C.A., Grey L., Ellis C., Moran M.F., Pawson T. Binding of SH2 domains of phospholipase Cg1, GAP and src to activated growth factor receptors. Science. 250:1990;979-982.
16. Moran M.F., Koch C.A., Anderson D., Ellis C., England L., Martin G.S., Pawson T. Src homology region 2 domains direct protein-protein interactions in signal transduction. Proc. Natl Acad. Sci. USA. 87:1990;8622-8626.
17. gag-fps. Mol. Cell. Biol. 6:1986;4396-4408.
18. Twamley G., Kypta R.M., Hall B., Courtneidge S.A. Association of Fyn with the activated platelet-derived growth factor receptor: requirements for binding and phosphorylation. Oncogene. 7:1992;1893-1901.
19. Alonso G., Koegl M., Mazurenko N., Courtneidge S.A. Sequence requirements for binding of Src family tyrosine kinases to activated growth factor receptors. J. Biol. Chem. 270:1995;9840-9848.
20. Mori S., Rönnstrand L., Yokote K., Engström A., Courtneidge S.A., Claesson-Welsh L., Heldin C.-H. Identification of two juxtamembrane autophosphorylation sites in the PDGF b-receptor; involvement in the interaction with the Src family tyrosine kinases. EMBO J. 12:1993;2257-2264.
21. Waksman G., Kominos D., Robertson S.R., Pant N., Baltimore D., Birge R.B., et al. Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine-phosphorylated peptides. Nature. 358:1992;646-653.
22. Waksman G., Shoelson S.E., Pant N., Cowburn D., Kuriyan J. Binding of a high affinity phosphotyrosyl peptide to the src SH2 domain: crystal structures of the complexed and peptide-free forms. Cell. 72:1993;779-790.
23. Payne G., Shoelson S.E., Gish G.D., Pawson T., Walsh C.T. Kinetics of p56lck and p60src Src homology 2 domain binding to tyrosine-phosphorylated peptides determined by a competition assay or surface plasmon resonance. Proc. Natl Acad. Sci. USA. 90:1993;4902-4906.
24. Gilmer T., Rodriguez M., Jordan S., Crosby R., Alligood K., Green M., et al. Peptide inhibitors of src SH3-SH2-phosphoprotein interactions. J. Biol. Chem. 269:1994;31711-31719.
25. Ladbury J.E., Wright J.G., Sturtevant J.M., Sigler P.B. A thermodynamic study of the trp repressor-operator interaction. J. Mol. Biol. 238:1994;669-681.
26. Ladbury J.E., Lemmon M.A., Zhou M., Green J., Botfield J., Schlessinger J. Measurement of the binding of tyrosyl phosphopeptides to SH2 domains: a reappraisal. Proc. Natl Acad. Sci. USA. 92:1995;3199-3203.
27. Bradshaw J.M., Grucza R.A., Ladbury J.E., Waksman G. Probing the "two pronged-plug two holed-socket" model for the mechanism of binding of the Src SH2 domain to phosphotyrosyl peptides: a thermodynamic study. Biochemistry. 37:1998;9083-9090.
28. Bradshaw J.M., Waksman G. Calorimetric investigation of proton linkage by monitoring both the enthalpy and association constant of binding: application to the interaction of the Src SH2 domain with a high affinity tyrosyl phosphopeptide. Biochemistry. 37:1998;15400-15407.
29. Bradshaw J.M., Waksman G. Calorimetric examination of high affinity Src SH2 domain-tyrosyl phosphopeptide binding: dissection of the phosphopeptide sequence specificity and coupling energetics. Biochemistry. 38:1999;5147-5154.
30. Bradshaw J.M., Mitaxov V., Waksman G. Investigation of phosphotyrosine recognition by the SH2 domain of the Src kinase. J. Mol. Biol. 293:1999;971-985.
31. Bradshaw J.M., Mitaxov V., Waksman G. Mutational investigation of the specificity determining region of the Src SH2 domain. J. Mol. Biol. 299:2000;521-535.
32. Grucza R.A., Bradshaw J.M., Mitaxov V., Waksman G. Role of electrostatic interactions in SH2 domain recognition: salt-dependence of tyrosyl-phosphorylated peptide binding to the tandem SH2 domain of the Syk kinase and the single SH2 domain of the Src kinase. Biochemistry. 39:2000;10072-10081.
33. Davidson J.P., Lubman O., Rose T., Waksman G., Martin S.F. Calorimetric and structural studies of 1,2,3-trisubstituted cyclopropanes as conformationally constrained peptide inhibitors of Src SH2 domain binding. J. Am. Chem. Soc. 124:2002;205-215.
34. Lubman O.Y., Waksman G. Dissection of the energetic coupling across the Src SH2 domain-tyrosyl phosphopeptide interface. J. Mol. Biol. 316:2002;291-304.
35. Songyang Z., Shoelson S.E., Chaudhuri M., Gish G., Pawson T., Haser W.G., et al. SH2 domains recognize specific phosphopeptide sequences. Cell. 72:1993;767-778.
36. Bradshaw J.M., Grucza R.A., Waksman G. Thermodynamics of protein modules involved in tyrosine kinase signaling pathways. Raffa R.B. Drug-receptor Thermodynamics: Introduction and Applications. 2001;451-470 Wiley, New York.
37. Bradshaw J.M., Waksman G. Molecular recognition by SH2 domains. Janin J. Advances in Protein Chemistry. vol. 61:2002;161-210.
38. Kuriyan J., Cowburn D. Modular peptide recognition domains in eukaryotic signaling. Annu. Rev. Biophys. Biomol. Struct. 26:1997;259-288.
39. Grucza R.A., Bradshaw J.M., Fütterer K., Waksman G. SH2 domains: from structure to energetics, a dual approach to the study of structure-function relationship. Med. Res. Rev. 19:1999;9491-9496.
40. Bradshaw J.M., Waksman G. SH2 domains. Creighton T.E. Encyclopedia of Molecular Medicine. 2000.
41. Dunitz J. The entropic cost of bound water in crystals and biomolecules. Science. 264:1994;670-674.
42. Vaughan C., Buckle A., Fersht A. Structural response to mutation at a protein-protein interface. J. Mol. Biol. 286:1999;1487-1506.
43. Clarke C., Woods R.J., Gluska J., Cooper A., Nutley M.A., Boons G.-J. Involvement of water in carbohydrate-protein binding. J. Am. Chem. Soc. 123:2001;12238-12247.
44. Weber T., Schaffhausen B., Liu Y., Gunther U.L. NMR structure of the N-SH2 of the p85 subunit of phosphoinositide 3-kinase complexed to a doubly phosphorylated peptide reveals a second phosphotyrosine binding site. Biochemistry. 39:2000;15860-15869.
45. Henriques D.A., Ladbury J.E. Inhibitors of the Src SH2 domain: a lesson in structure-thermodynamic correlation in drug design. Arch. Biochem. Biophys. 390:2001;158-168.
46. Renzoni D.A., Zvelebil M.J.J.M., Lundback T., Ladbury J.E. Exploring uncharted waters: water molecules in drug design strategies. Ladbury J.E., Connelly P.R. Structure-based Drug Design. 1997;R.G. Landes Inc, Austin TX, USA.
47. Tame J.R.H., Sleigh S.H., Wilkinson A.J., Ladbury J.E. The role of water in sequence-independent ligand binding by an oligopeptide transported protein. Nature Struct. Biol. 3:1996;998-1001.
48. Chung E., Henriques D., Renzoni D., Zvelebil M., Bradshaw J.M., Waksman G., et al. Mass spectrometric and thermodynamic studies reveal the role of water molecules in complexes formed between SH2 domains and tyrosyl phosphopeptides. Structure. 6:1998;1141-1151.
49. Gill S.C., von Hippel P.H. Calculation of protein extinction coefficients from amino acid data. Anal. Biochem. 182:1989;319-326.
50. Wiseman T., Williston S., Brandts J.F., Lin L.-N. Rapid measurement of binding constants and heats of binding using a new titration calorimeter. Anal. Biochem. 179:1989;131-137.
51. Otwinowski O., Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276:1997;307-326.
52. Brünger A.T., Adams P.D., Clore G.M., DeLano W.L., Gros P., Grosse-Kunstleve R.W., et al. Crystallography and NMR system: a new software suite for macromolecular structure determination. Acta Crystallog. sect. D. 54:1998;905-921.
53. Hodel A., Kim S.-H., Brünger A.T. Model bias in crystal structures. Acta Crystallog. sect. A. A48:1992;851-858.
54. Jones T.A., Zou J.Y., Cowan S.W., Kjeldgaard M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallog. sect. A. 47:1991;110-119.
55. Jones T.A., Thirup S. Using known substructures in protein model building and crystallography. EMBO J. 5:1986;819-822.
56. Carson M. Ribbons. Methods Enzymol. 277:1997;493-505.
57. lck. Nature. 362:1993;87-91.